MicroLactin (hyperimmune milk protein) and joint discomfort
What 2 graded rows on microlactin (hyperimmune milk protein) agree on for joint discomfort, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the MicroLactin (hyperimmune milk protein) page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the MicroLactin (hyperimmune milk protein) page, with its PubMed record.
Your question
MicroLactin (hyperimmune milk protein) and joint discomfort
2 rows · 89 peopleThey agree: both rows found an improvement.
- DGrade D× 2
- Rows
- 2
- Trials
- 2
- People
- 89
What the rows share
From the rowsThe best-graded row, grade D, is a randomized trial of 58 people (2019) and found an improvement.
The rows run from 31 to 58 people, published from 2002 to 2019: 2 single studies.
The rows
2 improved- DGrade DKnee discomfort (WOMAC, visual analogue scales) and 6-minute walk distance · Improved
RCT · n 58 · 2019 · Adults aged about 42–46 with mild to moderate knee pain during activity but no osteoarthritis diagnosis
4,000 mg/day (2,000 mg twice daily) · 8 weeks
6-minute walk distance improved 9% vs 2% with placebo (about 110 m difference), and 11 WOMAC items and 5 discomfort scales improved versus placebo. Blood safety markers stayed normal.
Row on the MicroLactin (hyperimmune milk protein) page · PubMed 30696041 (opens PubMed)
- DGrade DKnee osteoarthritis symptoms (WOMAC composite from KOOS) · Improved
RCT · n 31 · 2002 · Adults with osteoarthritis of both knees
12 oz/day · 6 weeks
The WOMAC composite improved more than with placebo (moderate effect size 0.56); safety indicators did not change.
Row on the MicroLactin (hyperimmune milk protein) page · PubMed 11985942 (opens PubMed)